Mark E. Ardron
2 Papers
Mark E. Ardron is an academic researcher. The author has contributed to research in topics: Stroke & Effective dose (pharmacology). The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Tolerability of the Low-Affinity, Use-Dependent NMDA Antagonist AR-R15896AR in Stroke Patients A Dose-Ranging Study
TL;DR: The maximum tolerated loading infusion of AR-R15896AR in this study was 250 mg over a period of 1 hour, and putative neuroprotective concentrations of 1240 ng/mL are attained by the loading dose and are satisfactorily maintained thereafter.
Impaired Dexterity of the Ipsilateral Hand After Stroke and the Relationship to Cognitive Deficit
TL;DR: Impairment was most severe after left hemisphere damage, and apraxia was a strong correlate of increased dexterity errors, whereas reduced ipsilateral grip strength correlated with slowing, while dexterity errors appeared to be due to visuospatial problems.